Annexon Biosciences's total assets for Q3 2025 were $229.14M, a decrease of -13.39% from the previous quarter. ANNX total liabilities were $67.70M for the fiscal quarter, a 3.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.